SCHEMBL16544647

SCHEMBL16544647

CN(C)Cc1cccc2c1-c1c(CN(C)C)cccc1C21c2ccccc2-c2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 6/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ CYP2D6 P10635 5/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ SLC6A2 P23975 8/20 0.38
▸ SLC6A4 P31645 8/20 0.38
▸ SLC6A3 Q01959 7/20 0.37
▸ LMNA P02545 3/20 0.36
▸ NPY1R P25929 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ NPY2R P49146 1/20 0.36
▸ TSHR P16473 2/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ CLK4 Q9HAZ1 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16544651 0.95 PDK2 (0.41) CYP1A2ALDH1A1CYP2D6CYP3A4KDM4E
SCHEMBL16544649 0.93 PDK2 (0.42) CYP1A2ALDH1A1CYP2D6CYP3A4KDM4E
SCHEMBL16544644 0.86 CYP1A2 (0.43) CYP1A2ALDH1A1CYP2D6CYP3A4KDM4E
SCHEMBL16544648 0.84 CYP1A2 (0.42) CYP1A2ALDH1A1CYP2D6CYP3A4KDM4E
SCHEMBL16544656 0.84 CYP1A2 (0.42) CYP1A2ALDH1A1CYP2D6CYP3A4KDM4E
SCHEMBL16544769 0.84 GABRA1 (0.40) CYP1A2ALDH1A1CYP2D6CYP3A4KDM4E
SCHEMBL19735235 0.80 LMNA (0.37) CYP1A2ALDH1A1CYP2D6CYP3A4KDM4E
SCHEMBL18079825 0.79 ADORA2A (0.42) CYP1A2ALDH1A1CYP2D6KDM4EHPGD
SCHEMBL15892355 0.77 PDK2 (0.36) ALDH1A1MAPK1TSHRMAPTHSD17B10
SCHEMBL18079822 0.77 PDK2 (0.43) CYP1A2ALDH1A1CYP2D6KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180019405-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-01-18 — — US disclosed
US-9812648-B2 Spirobifluorene compounds for organic electroluminescent devices MERCK PATENT GMBH (DE) 2017-11-07 — — US disclosed
US-20150065730-A1 SPIROBIFLUORENE COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-03-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180019405-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, EFNA1, EPCAM CYP1A2 390/4885ALDH1A1 33/4885CYP2D6 448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback